| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
See Remarks | Chief Medical Officer
1 company
Schwartz Jonathan David is a See Remarks at ROCKET PHARMACEUTICALS, INC.. Recent SEC Form 4 filings include 0 buys and 13 sells.
Estimated insider holdings value: $1.1M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 18, 2025 | RCKT Rocket Pharmaceuticals, Inc. | See Remarks | Sell | 2,545 | $2.98 | $7,591.74 | -0.8% | +12.6% | - | |
| Aug 19, 2025 | RCKT Rocket Pharmaceuticals, Inc. | See Remarks | Sell | 2,485 | $3.04 | $7,560.98 | -0.6% | +4.5% | - | |
| Aug 14, 2025 | RCKT Rocket Pharmaceuticals, Inc. | See Remarks | Sell | 11,161 | $3.02 | $33,695.06 | -4.7% | +8.9% | - | |
| May 20, 2025 | RCKT Rocket Pharmaceuticals, Inc. | See Remarks | Sell | 801 | $6.45 | $5,163.25 | -0.3% | -55.8% | - | |
| May 16, 2025 | RCKT Rocket Pharmaceuticals, Inc. | See Remarks | Sell | 1,582 | $6.53 | $10,327.30 | -0.7% | -53.4% | - | |
| Feb 25, 2025 | RCKT Rocket Pharmaceuticals, Inc. | See Remarks | Sell | 15,093 | $14.84 | $223,965.31 | -2.0% | -75.1% | -53.7% | |
| Feb 17, 2023 | RCKT Rocket Pharmaceuticals, Inc. | See Remarks | Sell | 3,557 | $19.06 | $67,796.42 | -3.6% | +9.2% | +54.0% | |
| Mar 30, 2022 | RCKT Rocket Pharmaceuticals, Inc. | See Remarks | Sell | 45,000 | $16.41 | $738,651.56 | -10.3% | -19.3% | +2.1% |